Journal articleJACC Cardiovasc Interv · December 2009
Featured Publication
OBJECTIVES: The aim of this study was to assess, after 2 years of follow-up, the safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent (ZES) compared with a paclitaxel-eluting stent (PES) in patients with native coronary lesions. BACKGROU ...
Full textLink to itemCite
Journal articleJACC Cardiovasc Interv · December 2009
Featured Publication
OBJECTIVES: This study was designed to evaluate long-term clinical and economic outcomes for subjects receiving Endeavor drug-eluting versus Driver bare-metal stents (both Medtronic CardioVascular, Santa Rosa, California). BACKGROUND: Early studies found t ...
Full textLink to itemCite
Journal articleJACC Cardiovasc Interv · December 2009
Featured Publication
OBJECTIVES: The aim of this study was to evaluate clinical and economic outcomes for subjects receiving zotarolimus-eluting (ZES) (n = 323) versus sirolimus-eluting stents (SES) (n = 113) in the ENDEAVOR III (Randomized Controlled Trial of the Medtronic En ...
Full textLink to itemCite
Journal articleAm J Med · February 2009
Featured Publication
BACKGROUND: Residence in a lower-income area has been associated with higher mortality among patients receiving dialysis. We sought to determine whether these differences persist and whether the effect of income-area on mortality is different for African A ...
Full textLink to itemCite
Journal articleStud Health Technol Inform · 2009
Featured Publication
Lower income individuals in the US frequently experience difficulties in obtaining access to needed health care services. We describe a randomized clinical trial that seeks to improve the quality of, and access to healthcare services for medically underser ...
Link to itemCite
Journal articleHealth Policy · December 2008
Featured Publication
OBJECTIVES: We sought to determine whether dialysis patient mortality rates are associated with differences in dialysis facility size, and whether this relationship differs among higher risk diabetic and lower-risk non-diabetic patients. METHODS: Using 186 ...
Full textLink to itemCite
Journal articleArch Intern Med · August 11, 2008
Featured Publication
BACKGROUND: Clinical trials of drug-eluting stents (DES) vs bare metal stents (BMS) report a reduced need for target lesion revascularization with no difference in death or myocardial infarction. However, these trials selectively enrolled patients with low ...
Full textLink to itemCite
Journal articleClin Trials · 2008
Featured Publication
BACKGROUND: Over the past decade, annual funding for biomedical research has more than doubled while new molecular entity approvals have declined by one third. OBJECTIVE: To assess the value of practices commonly employed in the conduct of large-scale clin ...
Full textLink to itemCite
Journal articleAMIA Annu Symp Proc · October 11, 2007
Featured Publication
Health information technology evaluators need to distinguish between intervention efficacy as assessed in the ideal circumstances of clinical trials and intervention effectiveness as assessed in the real world circumstances of actual practice. Because curr ...
Link to itemCite
Journal articleJAMA · February 7, 2007
Featured Publication
CONTEXT: In 1997, Congress authorized the US Food and Drug Administration (FDA) to grant 6-month extensions of marketing rights through the Pediatric Exclusivity Program if industry sponsors complete FDA-requested pediatric trials. The program has been pra ...
Full textOpen AccessLink to itemCite
Journal articleJAMA · January 10, 2007
Featured Publication
CONTEXT: Recent studies of drug-eluting intracoronary stents suggest that current antiplatelet regimens may not be sufficient to prevent late stent thrombosis. OBJECTIVE: To assess the association between clopidogrel use and long-term clinical outcomes of ...
Full textLink to itemCite
Journal articleJ Card Fail · June 2006
Featured Publication
BACKGROUND: The Digitalis Investigation Group (DIG) clinical train randomized 6800 congestive heart failure patients (ejection fraction > or =45%) to a daily regimen of either digoxin or placebo. At 37 months average follow-up, patients in both groups had ...
Full textLink to itemCite
Journal articleJ Electrocardiol · April 2006
Featured Publication
BACKGROUND AND PURPOSE: Health economic analyses seek to assess the relative value (cost vs health benefit trade-offs) of medical technologies. However, these methods have been underused in studies of the electrocardiogram (ECG). METHODS: We develop a fram ...
Full textLink to itemCite
Journal articleAMIA Annu Symp Proc · 2006
Featured Publication
Medical information systems are being recognized for their ability to improve patient outcomes. While standards for the economic evaluation of medical technologies were instituted in the mid-1990s, little is known about their application in medical informa ...
Link to itemCite
Journal articleAm J Med · September 2005
Featured Publication
PURPOSE: Obesity is a coronary disease risk factor, but its independent effect on clinical outcomes following acute coronary syndromes has not been quantified. We evaluated the relationship between elevated body mass index (BMI) and 30-day, 90-day, and 1-y ...
Full textLink to itemCite
Journal articleAnn Intern Med · April 19, 2005
Featured Publication
BACKGROUND: The Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II demonstrated that implantable cardioverter defibrillators (ICDs) save lives when used in patients with a history of myocardial infarction (MI) and an ejection fraction of 0.3 ...
Full textLink to itemCite
Journal articleAm Heart J · March 2005
Featured Publication
BACKGROUND: The pharmaceutical industry spends approximately 26.4 billion dollars annually for research and development (4.1 billion dollars in cardiovascular products). We compared pharmaceutical companies' planned resource use and costs in Phase III card ...
Full textLink to itemCite
Journal articleAMIA Annu Symp Proc · 2005
Featured Publication
Health information professionals recognize the need to demonstrate that the benefits of health information technological (HIT) interventions outweigh their costs. However, such cost-benefit analyses are rarely conducted for HIT interventions, due in part t ...
Link to itemCite
Journal articleAm Heart J · June 2002
Featured Publication
BACKGROUND: The Inhibition of Metallo Protease by BMS-186716 in a Randomized Exercise and Symptoms Study in Subjects With Heart Failure (IMPRESS) clinical trial randomized patients with congestive heart failure to a daily regimen of either omapatrilat or l ...
Full textLink to itemCite
Journal articleMed Care · August 2001
Featured Publication
BACKGROUND: The acute phase of coronary artery disease (CAD) is dramatic and receives much attention because of its high mortality and associated treatment cost. However, the acute phase typically resolves within 30 days whereas CAD is a chronic disease, w ...
Full textLink to itemCite
Journal articleN Engl J Med · March 16, 2000
Featured Publication
BACKGROUND: Reducing the length of hospitalizations can reduce short-term costs, but there are few data on the long-term clinical and economic consequences of early discharge. METHODS: Using data from the Global Utilization of Streptokinase and Tissue Plas ...
Full textLink to itemCite
Journal articleAnn Emerg Med · January 2000
Featured Publication
STUDY OBJECTIVE: Conventional emergency department testing strategies for patients with chest pain often do not provide unequivocal diagnosis of acute coronary syndromes. This study was conducted to determine whether the routine use of single photon emissi ...
Full textLink to itemCite
Journal articleJ Am Med Inform Assoc · 1994
Featured Publication
OBJECTIVES: To examine the influences of situational and model factors on the accuracy of Bayesian learning systems. DESIGN: This study examines the impacts of variations in two situational factors, training sample size and number of attributes, and in two ...
Full textLink to itemCite